Found: 8
Select item for more details and to access through your institution.
Therapeutic drug monitoring of immune checkpoint inhibitors: based on their pharmacokinetic properties and biomarkers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 3, p. 165, doi. 10.1007/s00280-023-04541-8
- By:
- Publication type:
- Article
Population pharmacokinetics and toxicity correlation analysis of free and liposome-encapsulated doxorubicin in Chinese patients with advanced breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 3, p. 181, doi. 10.1007/s00280-023-04559-y
- By:
- Publication type:
- Article
Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 3, p. 193, doi. 10.1007/s00280-023-04554-3
- By:
- Publication type:
- Article
External validation of a tumor growth inhibition-overall survival model in non-small-cell lung cancer based on atezolizumab studies using alectinib data.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 3, p. 205, doi. 10.1007/s00280-023-04558-z
- By:
- Publication type:
- Article
Veratricplatin inhibits the progression of hypopharyngeal squamous cell carcinoma FaDu cells in vitro and in vivo.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 3, p. 211, doi. 10.1007/s00280-023-04560-5
- By:
- Publication type:
- Article
Access to innovation through clinical trials and the national early access program for patients with lung cancer in France: focus on atezolizumab and durvalumab.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 3, p. 223, doi. 10.1007/s00280-023-04556-1
- By:
- Publication type:
- Article
Infections occurring following IL6 blockade for the management of cytokine release syndrome in onco-hematology patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 3, p. 229, doi. 10.1007/s00280-023-04551-6
- By:
- Publication type:
- Article
Cabozantinib-induced serum creatine kinase elevation and rhabdomyolysis: a retrospective case series.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 3, p. 235, doi. 10.1007/s00280-023-04557-0
- By:
- Publication type:
- Article